Melvin LK Chua, Head of the Department of Head Neck and Thoracic Cancers, Clinician-Scientist at National Center for Computational Sciences, shared on X:
“Fantastic tour to Shanghai to visit the Fudan University Cancer Centre Yao Zhu and speak on Precision Radiotherapy in Nasopharyngeal Carcinoma
- EBVDNA directed adaptation is prime time
- RT should be risk adapted – De-escalation vs Escalation
- Level 1 evidence needed
Nice to catch up with my fellow – Huang Luo again who joined me during COVID-19… how time flies!”
